Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I have never mentioned you, me or the Republicans. Check the post to which you are responding.
The Big Kahuna (aka Dr. Feelgood) knows more about this subject than I will ever hope to know, yet he never found it necessary to demean me or my posts. He's a good role model for all of us.
I don't mind the fact that he's smart and informative either, I just don't like his condescending air. And, the market doesn't seem to be enamored with his views either.
I'm certainly glad that you are able to discern the stupidity and dumbness of the other posters on the NNVC board. That makes it easier for me to sleep at night. (Sarcasm - for the humor challenged).
Why do you think that? In my opinion The tests being run by KARD differ little from all the previous animal tests. And, since they are being performed with non-GLP viricides I'm not sure what they are proving, except maybe whether there is any level of toxicity that will kill the specimens. I also thought that the NNVC lab was a certified cGLP facility. If so, why supply non GLP product to KARD?
What is the significance of starting the tox tests at KARD with non-GLP material? It is my understanding that non-GLP would not be accepted by the FDA, especially since Krishna Menon is atill affiliated with NNVC. Is this simply a trial run to see if they can kill the rats with enough of the stuff?
That borders on being libelous. I'd be more careful if I were you. Chat boards are not immune to discovery.
Peer reviews!!!!!! I'd much rather have the dozens of results from qualified clinicians from coast to coast than some fusty old professor huddled in the corner of his lab with his PEERs.
They needed to scale-up the old lab to make sufficient quantities of Flucide for tox studies. Those damned rats lived too long.
One needs to remember that this information is as of June 30. Things may have changed in the past three months. I hope so.
I commented several months back, when Dr. Seymour hinted at possible delays in receiving the lab equipment, that it was a precursor to the announcement of delays in the tox program. Ipso facto.
Tox deadline + 1.
What is a dept?
Beware!! Head for the hills!! Bunny is back from his hibernation. Welcome back, Bunny, we're still peering around that corner - looking for the bus.
The last date was end of third quarter. That's Monday. Cross your fingers for a PR.
Thanks. Those of us who have been around since 2005 tend to get a little panicky at times. I have total faith in the science and know it will benefit mankind beyond imagination. I just hate to see people who don't know the whole story 'diddle' with us like this.
Does anyone have a clue as to what is happening to NNVC share price? That's a $1.20 (21%)drop from yesterday's close and over $2 (27%) off the high? If this is our "Brave New World" you can have it.
How much of the volume prior to the up-listing could be attributed to other exhange indices re-balancing their portfolios a priori?
NO!!!!!
Management doesn't give a fig about your droning on and on about tox studies. They're busy doing them. And getting ready for human testing.
Who says they haven't started?
Why do you assume there is a problem?
J. Streicher is one of only six prestigious designated market makers on the NYSE. Privately owned, family business for over 100 years.Good company - Goldman Sachs, Barclays, .....
You're still sitting at that same bar with that same half empty glass.
Some of the big boys must be playing with the new kid on the block.
What just happened? That'a a dollar swing from day's high.
Fidelity is quoting volume but does not display on daily chart.
Cracked the resistance at 5.79.
The share price touched the 52 week high and then backed off.
When sellers are in charge, prices go down.
There was a Foucault pendulum in the Physics building at Georgia Tech when I was a student there. Amazing concept to prove earth's rotation.
Thanks, Doc Kahuna, for suffering the slings and arrows of outrageous fortune on our behalf.
Best wishes for a better cancer treatment. The 'Big C' would be a good target for NNVC after Cides.
Sokinlavv is panicking. What was your previous alias and how many shares are you short?
Just wait until NNVC's HepaCide hits the market. All these lawsuits will become 'moot'. Sofosbuvir will be left in the dust.
It appears that the NYSE requirements are the same as the ASE. This may be a result of the NYSE acquiring ASE.
Not likely.
If you read all the previous reports you would know that NNVC tried to find a manufacturing partner, but the cost and time required to deliver product was way more than NNVC's capability.
DR. Vivien Boniuk is a professor of ophthamology at Hofstra University on Long Island. I gather she was involved in the EKC studies at Beth Israel and was impressed enough to recommend NNVC to her father Milton. As they say. the rest is history.
Do you think NNVC could actually command a 50/50 split?
NVC is taken by a Nuveen California bond fund. Don't know if it precludes an AMEX stock with that symbol. NVC and NNV are available on AMEX. There are four letter symbols as well, so NNVC might stay.